| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Starling Oncology, Inc. (STLN) have been net sellers, shedding 286,853 shares worth roughly $1.9M on balance.
Counted by filing, the last 12 months brought 2 open-market purchases by 1 insider worth about $1.3M and 1 sale by 1 insider worth about $1.9M. There were none in the 12 months before that either.
The largest open-market purchase in the last two years was 398,985 shares by Jorey Chernett (10% Owner) at an average $3.07 on March 17, 2026, about $1.2M.
The most recent purchase was by Jorey Chernett (10% Owner) on August 14, 2026.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 10.66M | $69.94M | - | |
| CEO | 2.34M | $15.33M | - | |
| CFO | 414.8K | $2.72M | - | |
| Dir | 412.0K | $2.70M | - | |
| Other | 283.0K | $1.86M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 21, 2026 | Brad Hively79 | Director | Sell10b5-1 | 298,853 | $6.51 | $1,946,310.05 | -42.0% | |
| Aug 14, 2026 | Jorey Chernett66 | 10% Owner | Buy | 12,000 | $6.54 | $78,480.00 | +0.1% | |
| Mar 17, 2026 | Jorey Chernett66 | 10% Owner | Buy | 398,985 | $3.07 | $1,225,100.65 | +4.0% |